Status
Conditions
Treatments
About
The goal of this clinical trial is to compare the effectiveness of various root canal cleaning devices based on the principle of cavitation, ultrasonics, and conventional methods in a normal healthy adult population aged between 18 to 75 years requiring root canal treatment.
The main question[s] it aims to answer are:
Full description
Study title: "A Comparative Evaluation of Effectiveness in Root Canal Debridement using Inertial Cavitation Device vs Passive Ultrasonic Irrigation and Conventional Preparation: A Randomized Controlled Clinical Trial".
Study Design: This is a prospective, 3-arm randomized, non-blinded, single-center pivotal clinical investigation, performed to evaluate the effectiveness and safety of the Endoclean device with 2 comparator arms.
Primary objective: To test the effectiveness of the Endoclean device for root canal debridement up to 12-month follow-up.
Secondary objective: To test the extended effectiveness and safety of the Endoclean device up to a 24-month follow-up.
Inclusion/Exclusion Criteria:
Inclusion Criteria
•Patients aged between 18-75 years with ASA (American Society of Anesthesiologists) classification 1 and 2.
ASA 1: A normal healthy patient. Example: Fit, non-obese BMI (Body mass index) under 30, a non-smoking patient with good exercise tolerance.
ASA 2: A patient with mild systemic disease. Example: Patient with no functional limitations and a well-controlled disease (e.g., treated hypertension, obesity with BMI under 35, frequent social drinker, or cigarette smoker).
Exclusion Criteria:
Number of Participants:
Total number of participants = 109 subjects Arm 1: 40 subjects Arm 2: 40 subjects Arm 3: 29 subjects Test device: Endoclean (Lumendo AG): hydraulic cavitation cleaning device Control device 1: Passive ultrasonic irrigation (PUI) Control device 2: Rotary files with standard NaOCl irrigation Study duration: 2-3 years The results of the Endoclean group shall be compared to data gathered from the comparator device groups and results shall be presented in the clinical investigation report.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
•Patients aged between 18-75 years with ASA (American Society of Anesthesiologists) classification 1 and 2.
ASA 1: A normal healthy patient. Example: Fit, non-obese BMI (Body mass index) under 30, a non-smoking patient with good exercise tolerance.
ASA 2: A patient with mild systemic disease. Example: Patient with no functional limitations and a well-controlled disease (e.g., treated hypertension, obesity with BMI under 35, frequent social drinker, or cigarette smoker).
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
109 participants in 3 patient groups
Loading...
Central trial contact
Tan Fırat Eyüboglu Assoc. Prof.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal